Drug Metabolism Reviews

SJR Rank #5,505H-index: 117SJR: 0.930Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsDrug-Induced Hepatotoxicity and ProtectionComputational Drug Discovery MethodsCarcinogens and Genotoxicity AssessmentEicosanoids and Hypertension PharmacologyAnalytical Chemistry and ChromatographyMetabolism and Genetic DisordersMetabolomics and Mass Spectrometry StudiesDiverse Scientific and Economic Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs020406080

Documents per Year

2022202507142128

Detailed Information

ISSN

1097-9883, 0360-2532

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.79

References per Document

130.54

Coverage

1972, 1974-2026

Scope

Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.

Metrics from SCImago Journal Rank 2025. View on SCImago